Chest configuration in children and adolescents with infantile nephropathic cystinosis compared with other chronic kidney disease entities and its clinical determinants.
Müller S, Kluck R, Jagodzinski C, Brügelmann M, Hohenfellner K, Büscher A, Kemper MJ, Fröde K, Oh J, Billing H, Thumfart J, Weber LT, Acham-Roschitz B, Arbeiter K, Tönshoff B, Hagenberg M, Pavičić L, Haffner D, Zivicnjak M.
Pediatr Nephrol. 2023 Dec;38(12):3989-3999. doi: 10.1007/s00467-023-06058-x. Epub 2023 Jul 7.
Differences in kidney prognosis between congenital and infantile nephrotic syndrome.
Inoki Y, Horinouchi T, Aoyama S, Kimura Y, Ichikawa Y, Tanaka Y, Ueda C, Kitakado H, Kondo A, Sakakibara N, Kamei K, Hamada R, Fujita N, Gotoh Y, Kaku Y, Nishiyama K, Okamoto T, Toya Y, Yamamura T, Ishimori S, Nagano C, Nozu K.
Pediatr Nephrol. 2025 Aug;40(8):2539-2549. doi: 10.1007/s00467-025-06735-z. Epub 2025 Mar 17.
Idiopathic infantile hypercalcemia in children with chronic kidney disease due to kidney hypodysplasia.
Gurevich E, Borovitz Y, Levi S, Perlman S, Landau D.
Pediatr Nephrol. 2023 Apr;38(4):1067-1073. doi: 10.1007/s00467-022-05740-w. Epub 2022 Sep 26.
[Infantile polycystic kidney disease: a case report and literature review].
Luo F, Gu WZ, Chen Z, Shi LP, Ma XL, Lin HJ, Qiu YH.
Zhonghua Er Ke Za Zhi. 2013 May;51(5):377-81.
Beneficial effects of starting oral cysteamine treatment in the first 2 months of life on glomerular and tubular kidney function in infantile nephropathic cystinosis.
Hohenfellner K, Nießl C, Haffner D, Oh J, Okorn C, Palm K, Schlingmann KP, Wygoda S, Gahl WA.
Mol Genet Metab. 2022 Aug;136(4):282-288. doi: 10.1016/j.ymgme.2022.06.009. Epub 2022 Jul 1.
Relationship between age at initiation of cysteamine treatment, adherence with therapy, and glomerular kidney function in infantile nephropathic cystinosis.
Nießl C, Boulesteix AL, Oh J, Palm K, Schlingmann P, Wygoda S, Haffner D, Wühl E, Tönshoff B, Buescher A, Billing H, Hoppe B, Zirngibl M, Kettwig M, Moeller K, Acham-Roschitz B, Arbeiter K, Bald M, Benz M, Galiano M, John-Kroegel U, Klaus G, Marx-Berger D, Moser K, Mueller D, Patzer L, Pohl M, Seitz B, Treikauskas U, von Vigier RO, Gahl WA, Hohenfellner K.
Mol Genet Metab. 2022 Aug;136(4):268-273. doi: 10.1016/j.ymgme.2022.06.010. Epub 2022 Jul 2.
Inherited non-FGF23-mediated phosphaturic disorders: A kidney-centric review.
Walker E, Hayes W, Bockenhauer D.
Best Pract Res Clin Endocrinol Metab. 2024 Mar;38(2):101843. doi: 10.1016/j.beem.2023.101843. Epub 2023 Nov 25.
Treatment of hypophosphatasia.
Simon S, Resch H.
Wien Med Wochenschr. 2020 Apr;170(5-6):112-115. doi: 10.1007/s10354-020-00736-3. Epub 2020 Feb 18.
Kidney transplantation in infantile myofibromatosis and fibromuscular dysplasia: a case report.
Frezin J, Fusaro F, Reding R, Godefroid N.
J Med Case Rep. 2015 Nov 25;9:270. doi: 10.1186/s13256-015-0756-8.
Morphological changes and their associations with clinical parameters in children with nephropathic cystinosis and chronic kidney disease prior to kidney replacement therapy over 25 years.
Brügelmann M, Müller S, Bohlen AV, Hohenfellner K, Büscher A, Kemper MJ, Fröde K, Kanzelmeyer N, Oh J, Billing H, Gellermann J, Müller D, Weber LT, Acham-Roschitz B, Arbeiter K, Tönshoff B, Hagenberg M, Žebec MS, Haffner D, Zivicnjak M.
Pediatr Nephrol. 2024 Oct;39(10):3067-3077. doi: 10.1007/s00467-024-06421-6. Epub 2024 Jun 8.
